In addition, the risk score was also positively associated with the expression of INF-γ, IL-6, CCL2 and HLA-A (Supplementary Figure 10C and D), suggesting that macrophages and T cell mediated immune response were involved in high-risk group of glioma patients. Here, CCL2 is linked to central nervous system cancer.